instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Acute kidney injury'? | Acute Kidney Injury Associated With Semaglutide.
Case reports of acute kidney injury in patients taking the glucagon-like peptide 1 (GLP-1) receptor agonists exenatide and liraglutide have been reported. We report 2 patients with chronic kidney disease due to diabetic kidney disease who experienced rapid worsening of k... | Not recovered | ReactionOutcome | CC BY-NC-ND | 33851124 | 20,510,354 | 2021 |
What was the outcome of reaction 'Proteinuria'? | Acute Kidney Injury Associated With Semaglutide.
Case reports of acute kidney injury in patients taking the glucagon-like peptide 1 (GLP-1) receptor agonists exenatide and liraglutide have been reported. We report 2 patients with chronic kidney disease due to diabetic kidney disease who experienced rapid worsening of k... | Not recovered | ReactionOutcome | CC BY-NC-ND | 33851124 | 20,510,354 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor.
Drug-induced lupus glomerular diseases have historically been associated with hydralazine, but new drugs that modify the growth, metabolism, and immunity of cells are increasingly found to cause glomerular disease. This includes anti-tu... | CARVEDILOL, REGORAFENIB | DrugsGivenReaction | CC BY-NC-ND | 33851126 | 19,078,660 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atelectasis'. | Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor.
Drug-induced lupus glomerular diseases have historically been associated with hydralazine, but new drugs that modify the growth, metabolism, and immunity of cells are increasingly found to cause glomerular disease. This includes anti-tu... | CARVEDILOL, REGORAFENIB | DrugsGivenReaction | CC BY-NC-ND | 33851126 | 19,078,660 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor.
Drug-induced lupus glomerular diseases have historically been associated with hydralazine, but new drugs that modify the growth, metabolism, and immunity of cells are increasingly found to cause glomerular disease. This includes anti-tu... | CARVEDILOL, REGORAFENIB | DrugsGivenReaction | CC BY-NC-ND | 33851126 | 19,078,660 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Effusion'. | Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor.
Drug-induced lupus glomerular diseases have historically been associated with hydralazine, but new drugs that modify the growth, metabolism, and immunity of cells are increasingly found to cause glomerular disease. This includes anti-tu... | CARVEDILOL, REGORAFENIB | DrugsGivenReaction | CC BY-NC-ND | 33851126 | 19,078,660 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Generalised oedema'. | Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor.
Drug-induced lupus glomerular diseases have historically been associated with hydralazine, but new drugs that modify the growth, metabolism, and immunity of cells are increasingly found to cause glomerular disease. This includes anti-tu... | CARVEDILOL, REGORAFENIB | DrugsGivenReaction | CC BY-NC-ND | 33851126 | 19,078,660 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Glomerulonephritis proliferative'. | Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor.
Drug-induced lupus glomerular diseases have historically been associated with hydralazine, but new drugs that modify the growth, metabolism, and immunity of cells are increasingly found to cause glomerular disease. This includes anti-tu... | CARVEDILOL, REGORAFENIB | DrugsGivenReaction | CC BY-NC-ND | 33851126 | 19,078,660 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematuria'. | Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor.
Drug-induced lupus glomerular diseases have historically been associated with hydralazine, but new drugs that modify the growth, metabolism, and immunity of cells are increasingly found to cause glomerular disease. This includes anti-tu... | CARVEDILOL, REGORAFENIB | DrugsGivenReaction | CC BY-NC-ND | 33851126 | 19,078,660 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to lung'. | Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor.
Drug-induced lupus glomerular diseases have historically been associated with hydralazine, but new drugs that modify the growth, metabolism, and immunity of cells are increasingly found to cause glomerular disease. This includes anti-tu... | CARVEDILOL, REGORAFENIB | DrugsGivenReaction | CC BY-NC-ND | 33851126 | 19,078,660 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oedema peripheral'. | Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor.
Drug-induced lupus glomerular diseases have historically been associated with hydralazine, but new drugs that modify the growth, metabolism, and immunity of cells are increasingly found to cause glomerular disease. This includes anti-tu... | CARVEDILOL, REGORAFENIB | DrugsGivenReaction | CC BY-NC-ND | 33851126 | 19,078,660 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor.
Drug-induced lupus glomerular diseases have historically been associated with hydralazine, but new drugs that modify the growth, metabolism, and immunity of cells are increasingly found to cause glomerular disease. This includes anti-tu... | CARVEDILOL, REGORAFENIB | DrugsGivenReaction | CC BY-NC-ND | 33851126 | 19,078,660 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Proteinuria'. | Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor.
Drug-induced lupus glomerular diseases have historically been associated with hydralazine, but new drugs that modify the growth, metabolism, and immunity of cells are increasingly found to cause glomerular disease. This includes anti-tu... | CARVEDILOL, REGORAFENIB | DrugsGivenReaction | CC BY-NC-ND | 33851126 | 19,078,660 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary oedema'. | Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor.
Drug-induced lupus glomerular diseases have historically been associated with hydralazine, but new drugs that modify the growth, metabolism, and immunity of cells are increasingly found to cause glomerular disease. This includes anti-tu... | CARVEDILOL, REGORAFENIB | DrugsGivenReaction | CC BY-NC-ND | 33851126 | 19,078,660 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash macular'. | Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor.
Drug-induced lupus glomerular diseases have historically been associated with hydralazine, but new drugs that modify the growth, metabolism, and immunity of cells are increasingly found to cause glomerular disease. This includes anti-tu... | CARVEDILOL, REGORAFENIB | DrugsGivenReaction | CC BY-NC-ND | 33851126 | 19,078,660 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor.
Drug-induced lupus glomerular diseases have historically been associated with hydralazine, but new drugs that modify the growth, metabolism, and immunity of cells are increasingly found to cause glomerular disease. This includes anti-tu... | CARVEDILOL, REGORAFENIB | DrugsGivenReaction | CC BY-NC-ND | 33851126 | 19,078,660 | 2021 |
What was the administration route of drug 'REGORAFENIB'? | Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor.
Drug-induced lupus glomerular diseases have historically been associated with hydralazine, but new drugs that modify the growth, metabolism, and immunity of cells are increasingly found to cause glomerular disease. This includes anti-tu... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33851126 | 19,078,660 | 2021 |
What was the outcome of reaction 'Acute kidney injury'? | Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor.
Drug-induced lupus glomerular diseases have historically been associated with hydralazine, but new drugs that modify the growth, metabolism, and immunity of cells are increasingly found to cause glomerular disease. This includes anti-tu... | Recovering | ReactionOutcome | CC BY-NC-ND | 33851126 | 19,078,660 | 2021 |
What was the outcome of reaction 'Death'? | Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor.
Drug-induced lupus glomerular diseases have historically been associated with hydralazine, but new drugs that modify the growth, metabolism, and immunity of cells are increasingly found to cause glomerular disease. This includes anti-tu... | Fatal | ReactionOutcome | CC BY-NC-ND | 33851126 | 19,078,660 | 2021 |
What was the outcome of reaction 'Glomerulonephritis proliferative'? | Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor.
Drug-induced lupus glomerular diseases have historically been associated with hydralazine, but new drugs that modify the growth, metabolism, and immunity of cells are increasingly found to cause glomerular disease. This includes anti-tu... | Recovering | ReactionOutcome | CC BY-NC-ND | 33851126 | 19,078,660 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Antimicrobial treatment of Erysipelatoclostridium ramosum invasive infections: a systematic review.
The aim of this systematic review was to determine the causal role of Erysipelatoclostridium ramosum in specific invasive infections in humans, and to assess the clinical outcome of antibiotic therapy used to treat them.... | CEFTAZIDIME, METRONIDAZOLE | DrugsGivenReaction | CC BY-NC | 33852713 | 19,666,658 | 2021 |
What was the outcome of reaction 'Drug ineffective'? | Antimicrobial treatment of Erysipelatoclostridium ramosum invasive infections: a systematic review.
The aim of this systematic review was to determine the causal role of Erysipelatoclostridium ramosum in specific invasive infections in humans, and to assess the clinical outcome of antibiotic therapy used to treat them.... | Fatal | ReactionOutcome | CC BY-NC | 33852713 | 19,666,658 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anencephaly'. | Two cases of neural tube defects with dolutegravir use at conception in south Brazil.
Dolutegravir (DTG) is amongst the most prescribed antiretrovirals worldwide and is recommended as first line regimen in most HIV treatment guidelines. Its use, although infrequently, had been associated to an increased chance of neura... | DOLUTEGRAVIR, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY-NC-ND | 33852885 | 19,551,968 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal exposure during pregnancy'. | Two cases of neural tube defects with dolutegravir use at conception in south Brazil.
Dolutegravir (DTG) is amongst the most prescribed antiretrovirals worldwide and is recommended as first line regimen in most HIV treatment guidelines. Its use, although infrequently, had been associated to an increased chance of neura... | DOLUTEGRAVIR, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY-NC-ND | 33852885 | 19,551,968 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Low birth weight baby'. | Two cases of neural tube defects with dolutegravir use at conception in south Brazil.
Dolutegravir (DTG) is amongst the most prescribed antiretrovirals worldwide and is recommended as first line regimen in most HIV treatment guidelines. Its use, although infrequently, had been associated to an increased chance of neura... | DOLUTEGRAVIR, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY-NC-ND | 33852885 | 19,564,936 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature delivery'. | Two cases of neural tube defects with dolutegravir use at conception in south Brazil.
Dolutegravir (DTG) is amongst the most prescribed antiretrovirals worldwide and is recommended as first line regimen in most HIV treatment guidelines. Its use, although infrequently, had been associated to an increased chance of neura... | DOLUTEGRAVIR, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY-NC-ND | 33852885 | 19,564,936 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Spina bifida'. | Two cases of neural tube defects with dolutegravir use at conception in south Brazil.
Dolutegravir (DTG) is amongst the most prescribed antiretrovirals worldwide and is recommended as first line regimen in most HIV treatment guidelines. Its use, although infrequently, had been associated to an increased chance of neura... | DOLUTEGRAVIR, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY-NC-ND | 33852885 | 19,564,936 | 2021 |
What was the administration route of drug 'DOLUTEGRAVIR'? | Two cases of neural tube defects with dolutegravir use at conception in south Brazil.
Dolutegravir (DTG) is amongst the most prescribed antiretrovirals worldwide and is recommended as first line regimen in most HIV treatment guidelines. Its use, although infrequently, had been associated to an increased chance of neura... | Transplacental | DrugAdministrationRoute | CC BY-NC-ND | 33852885 | 19,551,968 | 2021 |
What was the administration route of drug 'LAMIVUDINE'? | Two cases of neural tube defects with dolutegravir use at conception in south Brazil.
Dolutegravir (DTG) is amongst the most prescribed antiretrovirals worldwide and is recommended as first line regimen in most HIV treatment guidelines. Its use, although infrequently, had been associated to an increased chance of neura... | Transplacental | DrugAdministrationRoute | CC BY-NC-ND | 33852885 | 19,551,968 | 2021 |
What was the administration route of drug 'TENOFOVIR DISOPROXIL FUMARATE'? | Two cases of neural tube defects with dolutegravir use at conception in south Brazil.
Dolutegravir (DTG) is amongst the most prescribed antiretrovirals worldwide and is recommended as first line regimen in most HIV treatment guidelines. Its use, although infrequently, had been associated to an increased chance of neura... | Transplacental | DrugAdministrationRoute | CC BY-NC-ND | 33852885 | 19,551,968 | 2021 |
What was the outcome of reaction 'Foetal exposure during pregnancy'? | Two cases of neural tube defects with dolutegravir use at conception in south Brazil.
Dolutegravir (DTG) is amongst the most prescribed antiretrovirals worldwide and is recommended as first line regimen in most HIV treatment guidelines. Its use, although infrequently, had been associated to an increased chance of neura... | Recovered | ReactionOutcome | CC BY-NC-ND | 33852885 | 19,551,968 | 2021 |
What was the outcome of reaction 'Premature delivery'? | Two cases of neural tube defects with dolutegravir use at conception in south Brazil.
Dolutegravir (DTG) is amongst the most prescribed antiretrovirals worldwide and is recommended as first line regimen in most HIV treatment guidelines. Its use, although infrequently, had been associated to an increased chance of neura... | Recovered | ReactionOutcome | CC BY-NC-ND | 33852885 | 19,564,936 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram QT prolonged'. | A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome.
FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) mutation in acute myeloid leukemia (AML) is associated with poor prognosi... | AZACITIDINE, HYDROXYUREA, QUIZARTINIB | DrugsGivenReaction | CC BY-NC | 33853292 | 19,191,482 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple organ dysfunction syndrome'. | A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome.
FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) mutation in acute myeloid leukemia (AML) is associated with poor prognosi... | AZACITIDINE, QUIZARTINIB | DrugsGivenReaction | CC BY-NC | 33853292 | 19,175,784 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sepsis'. | A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome.
FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) mutation in acute myeloid leukemia (AML) is associated with poor prognosi... | AZACITIDINE, QUIZARTINIB | DrugsGivenReaction | CC BY-NC | 33853292 | 19,175,784 | 2021-08-01 |
What was the administration route of drug 'AZACITIDINE'? | A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome.
FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) mutation in acute myeloid leukemia (AML) is associated with poor prognosi... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 33853292 | 19,175,784 | 2021-08-01 |
What was the administration route of drug 'QUIZARTINIB'? | A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome.
FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) mutation in acute myeloid leukemia (AML) is associated with poor prognosi... | Oral | DrugAdministrationRoute | CC BY-NC | 33853292 | 19,175,784 | 2021-08-01 |
What was the dosage of drug 'AZACITIDINE'? | A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome.
FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) mutation in acute myeloid leukemia (AML) is associated with poor prognosi... | 75 MILLIGRAM/SQ. METER | DrugDosageText | CC BY-NC | 33853292 | 19,175,784 | 2021-08-01 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome.
FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) mutation in acute myeloid leukemia (AML) is associated with poor prognosi... | Fatal | ReactionOutcome | CC BY-NC | 33853292 | 19,175,784 | 2021-08-01 |
What was the outcome of reaction 'Sepsis'? | A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome.
FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) mutation in acute myeloid leukemia (AML) is associated with poor prognosi... | Fatal | ReactionOutcome | CC BY-NC | 33853292 | 19,175,784 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'EGFR gene mutation'. | Lung Adenocarcinoma with Metachronous Ovarian Metastasis: a long survival case report.
Lung adenocarcinoma which invades ovaries is very rare. However, with the increase of long-survival female lung cancer, more patients will suffer ovarian metastasis. On grounds of the paucity of reported cases, the clinicopathologica... | GEFITINIB | DrugsGivenReaction | CC BY | 33853580 | 20,007,020 | 2021-04-14 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intestinal metastasis'. | Lung Adenocarcinoma with Metachronous Ovarian Metastasis: a long survival case report.
Lung adenocarcinoma which invades ovaries is very rare. However, with the increase of long-survival female lung cancer, more patients will suffer ovarian metastasis. On grounds of the paucity of reported cases, the clinicopathologica... | GEFITINIB | DrugsGivenReaction | CC BY | 33853580 | 20,007,020 | 2021-04-14 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to bladder'. | Lung Adenocarcinoma with Metachronous Ovarian Metastasis: a long survival case report.
Lung adenocarcinoma which invades ovaries is very rare. However, with the increase of long-survival female lung cancer, more patients will suffer ovarian metastasis. On grounds of the paucity of reported cases, the clinicopathologica... | GEFITINIB | DrugsGivenReaction | CC BY | 33853580 | 20,007,020 | 2021-04-14 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to ovary'. | Lung Adenocarcinoma with Metachronous Ovarian Metastasis: a long survival case report.
Lung adenocarcinoma which invades ovaries is very rare. However, with the increase of long-survival female lung cancer, more patients will suffer ovarian metastasis. On grounds of the paucity of reported cases, the clinicopathologica... | GEFITINIB | DrugsGivenReaction | CC BY | 33853580 | 20,007,020 | 2021-04-14 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to peritoneum'. | Lung Adenocarcinoma with Metachronous Ovarian Metastasis: a long survival case report.
Lung adenocarcinoma which invades ovaries is very rare. However, with the increase of long-survival female lung cancer, more patients will suffer ovarian metastasis. On grounds of the paucity of reported cases, the clinicopathologica... | GEFITINIB | DrugsGivenReaction | CC BY | 33853580 | 20,007,020 | 2021-04-14 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to uterus'. | Lung Adenocarcinoma with Metachronous Ovarian Metastasis: a long survival case report.
Lung adenocarcinoma which invades ovaries is very rare. However, with the increase of long-survival female lung cancer, more patients will suffer ovarian metastasis. On grounds of the paucity of reported cases, the clinicopathologica... | GEFITINIB | DrugsGivenReaction | CC BY | 33853580 | 20,007,020 | 2021-04-14 |
What was the administration route of drug 'GEFITINIB'? | Lung Adenocarcinoma with Metachronous Ovarian Metastasis: a long survival case report.
Lung adenocarcinoma which invades ovaries is very rare. However, with the increase of long-survival female lung cancer, more patients will suffer ovarian metastasis. On grounds of the paucity of reported cases, the clinicopathologica... | Oral | DrugAdministrationRoute | CC BY | 33853580 | 20,007,020 | 2021-04-14 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant neoplasm progression'. | Rapid Disease Progression in a Patient with Advanced NSCLC Harboring a Germline MET Exon 14 Skipping Mutation: A Case Report.
MET exon 14 skipping variants have been identified as a novel type of oncogenic driver mutations in non-small-cell lung cancer (NSCLC), while the germline MET mutation, especially germline MET e... | AFATINIB, CISPLATIN, PACLITAXEL | DrugsGivenReaction | CC BY-NC | 33854337 | 19,155,001 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | Rapid Disease Progression in a Patient with Advanced NSCLC Harboring a Germline MET Exon 14 Skipping Mutation: A Case Report.
MET exon 14 skipping variants have been identified as a novel type of oncogenic driver mutations in non-small-cell lung cancer (NSCLC), while the germline MET mutation, especially germline MET e... | AFATINIB, CISPLATIN, PACLITAXEL | DrugsGivenReaction | CC BY-NC | 33854337 | 19,155,001 | 2021 |
What was the administration route of drug 'AFATINIB'? | Rapid Disease Progression in a Patient with Advanced NSCLC Harboring a Germline MET Exon 14 Skipping Mutation: A Case Report.
MET exon 14 skipping variants have been identified as a novel type of oncogenic driver mutations in non-small-cell lung cancer (NSCLC), while the germline MET mutation, especially germline MET e... | Oral | DrugAdministrationRoute | CC BY-NC | 33854337 | 19,155,001 | 2021 |
What was the dosage of drug 'AFATINIB'? | Rapid Disease Progression in a Patient with Advanced NSCLC Harboring a Germline MET Exon 14 Skipping Mutation: A Case Report.
MET exon 14 skipping variants have been identified as a novel type of oncogenic driver mutations in non-small-cell lung cancer (NSCLC), while the germline MET mutation, especially germline MET e... | 40 mg (milligrams). | DrugDosage | CC BY-NC | 33854337 | 19,155,001 | 2021 |
What was the outcome of reaction 'Respiratory failure'? | Rapid Disease Progression in a Patient with Advanced NSCLC Harboring a Germline MET Exon 14 Skipping Mutation: A Case Report.
MET exon 14 skipping variants have been identified as a novel type of oncogenic driver mutations in non-small-cell lung cancer (NSCLC), while the germline MET mutation, especially germline MET e... | Fatal | ReactionOutcome | CC BY-NC | 33854337 | 19,155,001 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Adenocarcinoma in a Recurrent Retrorectal Cyst: A Case Report.
I present a case of an adenocarcinoma in a retrorectal cyst in a 63-year-old female with a prior history of a congenital cyst excised as a newborn. The patient had a resection with positive margins, followed by chemotherapy and radiotherapy at progression. ... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33854384 | 20,144,258 | 2021 |
What was the outcome of reaction 'Disease progression'? | Adenocarcinoma in a Recurrent Retrorectal Cyst: A Case Report.
I present a case of an adenocarcinoma in a retrorectal cyst in a 63-year-old female with a prior history of a congenital cyst excised as a newborn. The patient had a resection with positive margins, followed by chemotherapy and radiotherapy at progression. ... | Fatal | ReactionOutcome | CC BY-NC | 33854384 | 20,144,258 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Cushing's Syndrome With Nocardiosis: A Case Report and a Systematic Review of the Literature.
To analyze and summarize the clinical characteristics, treatments, and prognosis of Cushing's syndrome (CS) with nocardiosis.
A patient in our hospital and additional 17 patients of CS with nocardiosis in the English litera... | AMPHOTERICIN B, CEFTRIAXONE, INSULIN NOS, MOXIFLOXACIN, POTASSIUM CHLORIDE, SPIRONOLACTONE, SULFAMETHOXAZOLE\TRIMETHOPRIM, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 33854481 | 19,990,635 | 2021 |
What was the dosage of drug 'AMPHOTERICIN B'? | Cushing's Syndrome With Nocardiosis: A Case Report and a Systematic Review of the Literature.
To analyze and summarize the clinical characteristics, treatments, and prognosis of Cushing's syndrome (CS) with nocardiosis.
A patient in our hospital and additional 17 patients of CS with nocardiosis in the English litera... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY | 33854481 | 19,990,635 | 2021 |
What was the dosage of drug 'CEFTRIAXONE'? | Cushing's Syndrome With Nocardiosis: A Case Report and a Systematic Review of the Literature.
To analyze and summarize the clinical characteristics, treatments, and prognosis of Cushing's syndrome (CS) with nocardiosis.
A patient in our hospital and additional 17 patients of CS with nocardiosis in the English litera... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY | 33854481 | 19,990,635 | 2021 |
What was the dosage of drug 'INSULIN NOS'? | Cushing's Syndrome With Nocardiosis: A Case Report and a Systematic Review of the Literature.
To analyze and summarize the clinical characteristics, treatments, and prognosis of Cushing's syndrome (CS) with nocardiosis.
A patient in our hospital and additional 17 patients of CS with nocardiosis in the English litera... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY | 33854481 | 19,990,635 | 2021 |
What was the dosage of drug 'MOXIFLOXACIN'? | Cushing's Syndrome With Nocardiosis: A Case Report and a Systematic Review of the Literature.
To analyze and summarize the clinical characteristics, treatments, and prognosis of Cushing's syndrome (CS) with nocardiosis.
A patient in our hospital and additional 17 patients of CS with nocardiosis in the English litera... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY | 33854481 | 19,990,635 | 2021 |
What was the dosage of drug 'POTASSIUM CHLORIDE'? | Cushing's Syndrome With Nocardiosis: A Case Report and a Systematic Review of the Literature.
To analyze and summarize the clinical characteristics, treatments, and prognosis of Cushing's syndrome (CS) with nocardiosis.
A patient in our hospital and additional 17 patients of CS with nocardiosis in the English litera... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY | 33854481 | 19,990,635 | 2021 |
What was the dosage of drug 'SPIRONOLACTONE'? | Cushing's Syndrome With Nocardiosis: A Case Report and a Systematic Review of the Literature.
To analyze and summarize the clinical characteristics, treatments, and prognosis of Cushing's syndrome (CS) with nocardiosis.
A patient in our hospital and additional 17 patients of CS with nocardiosis in the English litera... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY | 33854481 | 19,990,635 | 2021 |
What was the dosage of drug 'SULFAMETHOXAZOLE\TRIMETHOPRIM'? | Cushing's Syndrome With Nocardiosis: A Case Report and a Systematic Review of the Literature.
To analyze and summarize the clinical characteristics, treatments, and prognosis of Cushing's syndrome (CS) with nocardiosis.
A patient in our hospital and additional 17 patients of CS with nocardiosis in the English litera... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY | 33854481 | 19,990,635 | 2021 |
What was the dosage of drug 'UNSPECIFIED INGREDIENT'? | Cushing's Syndrome With Nocardiosis: A Case Report and a Systematic Review of the Literature.
To analyze and summarize the clinical characteristics, treatments, and prognosis of Cushing's syndrome (CS) with nocardiosis.
A patient in our hospital and additional 17 patients of CS with nocardiosis in the English litera... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY | 33854481 | 19,990,635 | 2021 |
What was the outcome of reaction 'Drug ineffective'? | Cushing's Syndrome With Nocardiosis: A Case Report and a Systematic Review of the Literature.
To analyze and summarize the clinical characteristics, treatments, and prognosis of Cushing's syndrome (CS) with nocardiosis.
A patient in our hospital and additional 17 patients of CS with nocardiosis in the English litera... | Fatal | ReactionOutcome | CC BY | 33854481 | 19,990,635 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'No adverse event'. | Early anti IL-1 treatment replaces steroids in refractory Kawasaki disease: clinical experience from two case reports.
Refractory Kawasaki disease (KD) is related to a major risk of coronary arteries abnormalities and its treatment is not standardized. In this regard, anakinra (ANA), an interleukin (IL)-1 receptor anta... | ASPIRIN, HUMAN IMMUNOGLOBULIN G | DrugsGivenReaction | CC BY-NC | 33854568 | 19,232,994 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Early anti IL-1 treatment replaces steroids in refractory Kawasaki disease: clinical experience from two case reports.
Refractory Kawasaki disease (KD) is related to a major risk of coronary arteries abnormalities and its treatment is not standardized. In this regard, anakinra (ANA), an interleukin (IL)-1 receptor anta... | ASPIRIN, HUMAN IMMUNOGLOBULIN G | DrugsGivenReaction | CC BY-NC | 33854568 | 19,232,994 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Early anti IL-1 treatment replaces steroids in refractory Kawasaki disease: clinical experience from two case reports.
Refractory Kawasaki disease (KD) is related to a major risk of coronary arteries abnormalities and its treatment is not standardized. In this regard, anakinra (ANA), an interleukin (IL)-1 receptor anta... | ASPIRIN, HUMAN IMMUNOGLOBULIN G | DrugsGivenReaction | CC BY-NC | 33854568 | 19,232,994 | 2021 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Early anti IL-1 treatment replaces steroids in refractory Kawasaki disease: clinical experience from two case reports.
Refractory Kawasaki disease (KD) is related to a major risk of coronary arteries abnormalities and its treatment is not standardized. In this regard, anakinra (ANA), an interleukin (IL)-1 receptor anta... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33854568 | 19,232,994 | 2021 |
What was the dosage of drug 'HUMAN IMMUNOGLOBULIN G'? | Early anti IL-1 treatment replaces steroids in refractory Kawasaki disease: clinical experience from two case reports.
Refractory Kawasaki disease (KD) is related to a major risk of coronary arteries abnormalities and its treatment is not standardized. In this regard, anakinra (ANA), an interleukin (IL)-1 receptor anta... | 2 GRAM PER KILOGRAM | DrugDosageText | CC BY-NC | 33854568 | 19,232,994 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Super-refractory status epilepticus in a 29-year-old pregnant female.
Super-refractory status epilepticus is a rare medical and neurological emergency due to the high mortality and morbidity associated with this condition. Furthermore, there is very little data regarding its incidence, etiology, and management in the p... | FOSPHENYTOIN, KETAMINE, LACOSAMIDE, LEVETIRACETAM, LORAZEPAM, MAGNESIUM, MIDAZOLAM, PENTOBARBITAL, PROPOFOL | DrugsGivenReaction | CC BY-NC | 33854779 | 19,176,847 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal distress syndrome'. | Super-refractory status epilepticus in a 29-year-old pregnant female.
Super-refractory status epilepticus is a rare medical and neurological emergency due to the high mortality and morbidity associated with this condition. Furthermore, there is very little data regarding its incidence, etiology, and management in the p... | FOSPHENYTOIN, KETAMINE, LACOSAMIDE, LEVETIRACETAM, LORAZEPAM, MAGNESIUM, MIDAZOLAM, PENTOBARBITAL, PROPOFOL | DrugsGivenReaction | CC BY-NC | 33854779 | 19,176,847 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Super-refractory status epilepticus in a 29-year-old pregnant female.
Super-refractory status epilepticus is a rare medical and neurological emergency due to the high mortality and morbidity associated with this condition. Furthermore, there is very little data regarding its incidence, etiology, and management in the p... | FOSPHENYTOIN, KETAMINE, LACOSAMIDE, LEVETIRACETAM, LORAZEPAM, MAGNESIUM, MIDAZOLAM, PENTOBARBITAL, PROPOFOL | DrugsGivenReaction | CC BY-NC | 33854779 | 19,176,834 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature baby'. | Super-refractory status epilepticus in a 29-year-old pregnant female.
Super-refractory status epilepticus is a rare medical and neurological emergency due to the high mortality and morbidity associated with this condition. Furthermore, there is very little data regarding its incidence, etiology, and management in the p... | FOSPHENYTOIN, KETAMINE, LACOSAMIDE, LEVETIRACETAM, LORAZEPAM, MAGNESIUM, MIDAZOLAM, PENTOBARBITAL, PROPOFOL | DrugsGivenReaction | CC BY-NC | 33854779 | 19,176,834 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature delivery'. | Super-refractory status epilepticus in a 29-year-old pregnant female.
Super-refractory status epilepticus is a rare medical and neurological emergency due to the high mortality and morbidity associated with this condition. Furthermore, there is very little data regarding its incidence, etiology, and management in the p... | FOSPHENYTOIN, KETAMINE, LACOSAMIDE, LEVETIRACETAM, LORAZEPAM, MAGNESIUM, MIDAZOLAM, PENTOBARBITAL, PROPOFOL | DrugsGivenReaction | CC BY-NC | 33854779 | 19,176,847 | 2021 |
What was the administration route of drug 'KETAMINE'? | Super-refractory status epilepticus in a 29-year-old pregnant female.
Super-refractory status epilepticus is a rare medical and neurological emergency due to the high mortality and morbidity associated with this condition. Furthermore, there is very little data regarding its incidence, etiology, and management in the p... | Transplacental | DrugAdministrationRoute | CC BY-NC | 33854779 | 19,176,834 | 2021 |
What was the administration route of drug 'MIDAZOLAM'? | Super-refractory status epilepticus in a 29-year-old pregnant female.
Super-refractory status epilepticus is a rare medical and neurological emergency due to the high mortality and morbidity associated with this condition. Furthermore, there is very little data regarding its incidence, etiology, and management in the p... | Transplacental | DrugAdministrationRoute | CC BY-NC | 33854779 | 19,176,834 | 2021 |
What was the administration route of drug 'PENTOBARBITAL'? | Super-refractory status epilepticus in a 29-year-old pregnant female.
Super-refractory status epilepticus is a rare medical and neurological emergency due to the high mortality and morbidity associated with this condition. Furthermore, there is very little data regarding its incidence, etiology, and management in the p... | Transplacental | DrugAdministrationRoute | CC BY-NC | 33854779 | 19,176,834 | 2021 |
What was the administration route of drug 'PROPOFOL'? | Super-refractory status epilepticus in a 29-year-old pregnant female.
Super-refractory status epilepticus is a rare medical and neurological emergency due to the high mortality and morbidity associated with this condition. Furthermore, there is very little data regarding its incidence, etiology, and management in the p... | Transplacental | DrugAdministrationRoute | CC BY-NC | 33854779 | 19,176,834 | 2021 |
What was the dosage of drug 'PENTOBARBITAL'? | Super-refractory status epilepticus in a 29-year-old pregnant female.
Super-refractory status epilepticus is a rare medical and neurological emergency due to the high mortality and morbidity associated with this condition. Furthermore, there is very little data regarding its incidence, etiology, and management in the p... | 2 MG/KG/H | DrugDosageText | CC BY-NC | 33854779 | 19,176,834 | 2021 |
What was the dosage of drug 'PROPOFOL'? | Super-refractory status epilepticus in a 29-year-old pregnant female.
Super-refractory status epilepticus is a rare medical and neurological emergency due to the high mortality and morbidity associated with this condition. Furthermore, there is very little data regarding its incidence, etiology, and management in the p... | 55 MCG/KG/MIN | DrugDosageText | CC BY-NC | 33854779 | 19,176,834 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal pain'. | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | ALCOHOL, THEOPHYLLINE ANHYDROUS | DrugsGivenReaction | CC BY | 33854801 | 19,256,050 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood glucose increased'. | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | ADENOSINE, THEOPHYLLINE ANHYDROUS | DrugsGivenReaction | CC BY | 33854801 | 19,272,955 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood pressure decreased'. | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | ALCOHOL, THEOPHYLLINE ANHYDROUS | DrugsGivenReaction | CC BY | 33854801 | 19,256,050 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | ADENOSINE, THEOPHYLLINE ANHYDROUS | DrugsGivenReaction | CC BY | 33854801 | 19,272,955 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyspnoea'. | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | ALCOHOL, THEOPHYLLINE ANHYDROUS | DrugsGivenReaction | CC BY | 33854801 | 19,256,050 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Labelled drug-drug interaction issue'. | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | ADENOSINE, THEOPHYLLINE ANHYDROUS | DrugsGivenReaction | CC BY | 33854801 | 19,200,101 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Labelled drug-drug interaction medication error'. | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | ADENOSINE, THEOPHYLLINE ANHYDROUS | DrugsGivenReaction | CC BY | 33854801 | 19,247,741 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | ADENOSINE, THEOPHYLLINE ANHYDROUS | DrugsGivenReaction | CC BY | 33854801 | 19,200,101 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Palpitations'. | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | ALCOHOL, THEOPHYLLINE ANHYDROUS | DrugsGivenReaction | CC BY | 33854801 | 19,256,050 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sinus tachycardia'. | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | ALCOHOL, THEOPHYLLINE ANHYDROUS | DrugsGivenReaction | CC BY | 33854801 | 19,256,050 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | ALCOHOL, THEOPHYLLINE ANHYDROUS | DrugsGivenReaction | CC BY | 33854801 | 19,256,050 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | ADENOSINE, THEOPHYLLINE ANHYDROUS | DrugsGivenReaction | CC BY | 33854801 | 19,272,955 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | ALCOHOL, THEOPHYLLINE ANHYDROUS | DrugsGivenReaction | CC BY | 33854801 | 19,256,050 | 2021 |
What was the dosage of drug 'THEOPHYLLINE ANHYDROUS'? | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | CHRONIC TREATMENT | DrugDosageText | CC BY | 33854801 | 19,272,955 | 2021 |
What was the outcome of reaction 'Abdominal pain'? | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | Recovered | ReactionOutcome | CC BY | 33854801 | 19,256,050 | 2021 |
What was the outcome of reaction 'Arrhythmia'? | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | Recovered | ReactionOutcome | CC BY | 33854801 | 19,256,050 | 2021 |
What was the outcome of reaction 'Blood glucose increased'? | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | Recovering | ReactionOutcome | CC BY | 33854801 | 19,272,955 | 2021 |
What was the outcome of reaction 'Blood pressure decreased'? | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | Recovered | ReactionOutcome | CC BY | 33854801 | 19,256,050 | 2021 |
What was the outcome of reaction 'Dyspnoea'? | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | Recovered | ReactionOutcome | CC BY | 33854801 | 19,256,050 | 2021 |
What was the outcome of reaction 'Hypotension'? | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | Recovered | ReactionOutcome | CC BY | 33854801 | 19,272,955 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.